Skip to main content

Table 2 Anthropometric index and body composition characteristics at baseline and after 8 weeks of intervention

From: The effects of portfolio moderate-carbohydrate and ketogenic diets on anthropometric indices, metabolic status, and hormonal levels in overweight or obese women with polycystic ovary syndrome: a randomized controlled trial

Variables

 

PLCD (n = 21)

KD (n = 19)

MD (CI%95)

P-value†

P-value

Weight (kg)

Baseline

78.49 (11.61)

79.02 (12.34)

-0.52

0.88

P < 0.05*

8 weeks

74.14 (11.29)

73.38 (11.35)

0.76

0.83

P < 0.05§

MD (CI%95)

4.35 (3.64, 5.56)

5.64 (8.53, 7.55)

 

P-value

P < 0.05

P < 0.05

BMI (kg/m2)

Baseline

29.47 (4.25)

29.21 (3.39)

0.26

0.496

P < 0.05*

8 weeks

27.76 (3.89)

26.48 (3.56)

1.28

0.286

P < 0.05**

MD (CI%95)

1.71 (1.36, 2.07)

2.90 (2.73, 3.07)

 

p-Value

P < 0.05

P < 0.05

WC (cm)

Baseline

104.19 (10.89)

105.62 (12.03)

-1.42

0.67

P < 0.05*

8 weeks

101.49 (10.17)

100.18 (12.34)

1.30

0.71

P < 0.05**

MD (CI%95)

2.70 (2.07, 3.34)

5.44 (6.74, 8.10)

 

P-value

P < 0.05

P < 0.05

HC (cm)

Baseline

113.96 (10.68)

114.65 (11.42)

-0.68

0.83

P < 0.05*

8 weeks

110.73 (11.16)

109.61 (12.88)

1.12

0.76

P < 0.05**

MD (CI%95)

3.44 (2.81, 4.07)

7.31 (5.04, 9.57)

 

P-value

P < 0.05

P < 0.05

WHR

Baseline

0.914 (0.034)

0.920 (0.026)

-0.006

0.769

0.338*

8 weeks

0.917 (0.039)

0.914 (0.049)

0.002

0.855

0.529**

MD (CI%95)

-0.005 (-0.01, 0.003)

0.004 (-0.014, 0.023)

 

P-value

0.243

P < 0.05

FBM (kg)

Baseline

29.86 (6.93)

28.77 (7.04)

1.09

0.598

P < 0.05*

8 weeks

26.74 (6.26)

24.42 (6.99)

2.32

0.275

P < 0.05**

MD (CI%95)

3.08 (2.06, 4.10)

5.18 (4.26, 5.75)

 

P-value

P < 0.05

P < 0.05

LBM (kg)

Baseline

50.01 (5.50)

50.24 (6.21)

-0.230

0.895

P < 0.05*

8 weeks

48.61(5.31)

48.62 (5.14)

-0.006

0.997

P < 0.05**

MD (CI%95)

1.35 (0.67, 2.04)

3.19 (2.64, 3.74)

 

P-value

P < 0.05

P < 0.05

TBW (kg)

Baseline

36.00 (3.97)

36.18 (4.47)

-0.17

0.887

P < 0.05*

8 weeks

35.01(4.07)

35.16 (3.52)

-0.14

0.903

P < 0.05**

MD (CI%95)

0.96 (0.51, 1.41)

2.15(1.74, 2.55)

 

P-value

P < 0.05

P < 0.05

TBP (kg)

Baseline

9.50 (0.98)

9.61 (1.13)

-0.10

0.730

P < 0.05*

8 weeks

9.19(1.04)

9.35 (1.02)

-0.16

0.622

P < 0.05**

MD (CI%95)

0.30 (0.21, 0.40)

0.56 (0.38, 0.74)

 

P-value

P < 0.05

P < 0.05

TBM (kg)

Baseline

4.49 (0.63)

4.45 (0.67)

0.03

0.841

0.541*

8 weeks

4.20 (0.71)

4.34 (0.68)

-0.14

0.510

0.551**

MD (CI%95)

0.29 (0.17, 0.40)

0.24 (0.15, 0.32)

 

P-value

P < 0.05

P < 0.05

RMR (Kcal)

Baseline

1300.00 (80.60)

1305.86 (86.78)

-5.86

0.813

0.665*

8 weeks

1280.33(84.18)

1298.74 (73.15)

-18.04

0.467

0.488**

MD (CI%95)

18.19 (3.67, 32.70)

27.05 (4.26, 49.83)

 

P-value

P < 0.05

P < 0.05

  1. Data are expressed as mean (SD) and mean difference (95%CI)
  2. †Indicate comparison between groups at baseline (Independent samples t-test for baseline)
  3. *Indicate comparison between groups based on ANOVA without adjustment
  4. **Indicate comparison between groups based on ANOVA adjusted for baseline measures and confounding factors (age, baseline BMI, physical activity, and, energy intake)
  5. §Indicate comparison between groups based on ANOVA adjusted for baseline measures and confounding factors (age, physical activity, resting metabolite rate, and, energy intake)
  6. Abbreviations: BMI body mass index, WC waist circumferences, HC hip circumferences, WHR waist to hip ratio, FBM fat body mass, LBM lean body mass, TBW total body water, TBP total body protein, TBM total body mineral, RMR resting metabolic rate